In Reply to Gupta et al
- PMID: 32589992
- PMCID: PMC7218371
- DOI: 10.1016/j.ijrobp.2020.04.032
In Reply to Gupta et al
Comment on
-
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627. doi: 10.1016/j.ijrobp.2020.04.016. Epub 2020 Apr 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32302681 Free PMC article.
-
In Regard to Thomson et al.Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):853-854. doi: 10.1016/j.ijrobp.2020.04.031. Epub 2020 May 13. Int J Radiat Oncol Biol Phys. 2020. PMID: 32589991 Free PMC article. No abstract available.
References
-
- Thomson D.J., Palma D., Guckenberger M. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement [e-pub ahead of print] Int J Radiat Oncol Biol Phys. 2020 doi: 10.1016/j.ijrobp.2020.04.016. accessed May 12, 2020. - DOI - PMC - PubMed
-
- U.S. National Library of Medicine. Resource sparing curative radiotherapy for locally advanced squamous cell cancer of the head and neck: The HYPNO Trial (HYPNO). Available at: https://clinicaltrials.gov/ct2/show/NCT02765503. Accessed May 12, 2020.
-
- The Royal College of Radiologists Head and neck cancer and COVID-19. https://www.rcr.ac.uk/sites/default/files/head-and-neck-cancer-treatment... Available at: Accessed May 12, 2020.